BlackRock’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-4,949,917
| Closed | -$748M | – | 5896 |
|
2022
Q3 | $748M | Sell |
4,949,917
-122,158
| -2% | -$18.5M | 0.03% | 598 |
|
2022
Q2 | $739M | Buy |
5,072,075
+415,209
| +9% | +$60.5M | 0.02% | 625 |
|
2022
Q1 | $552M | Buy |
4,656,866
+21,586
| +0.5% | +$2.56M | 0.01% | 895 |
|
2021
Q4 | $639M | Buy |
4,635,280
+28,207
| +0.6% | +$3.89M | 0.02% | 848 |
|
2021
Q3 | $640M | Sell |
4,607,073
-84,505
| -2% | -$11.7M | 0.02% | 808 |
|
2021
Q2 | $455M | Buy |
4,691,578
+908,024
| +24% | +$88.2M | 0.01% | 1084 |
|
2021
Q1 | $259M | Buy |
3,783,554
+258,603
| +7% | +$17.7M | 0.01% | 1527 |
|
2020
Q4 | $302M | Buy |
3,524,951
+76,411
| +2% | +$6.55M | 0.01% | 1297 |
|
2020
Q3 | $224M | Sell |
3,448,540
-82,786
| -2% | -$5.38M | 0.01% | 1290 |
|
2020
Q2 | $258M | Buy |
3,531,326
+260,157
| +8% | +$19M | 0.01% | 1164 |
|
2020
Q1 | $111M | Buy |
3,271,169
+352,828
| +12% | +$12M | 0.01% | 1565 |
|
2019
Q4 | $159M | Buy |
2,918,341
+16,218
| +0.6% | +$883K | 0.01% | 1659 |
|
2019
Q3 | $121M | Buy |
2,902,123
+411,603
| +17% | +$17.2M | 0.01% | 1772 |
|
2019
Q2 | $109M | Sell |
2,490,520
-368,373
| -13% | -$16.1M | ﹤0.01% | 1837 |
|
2019
Q1 | $147M | Buy |
2,858,893
+465,745
| +19% | +$24M | 0.01% | 1630 |
|
2018
Q4 | $88.5M | Buy |
2,393,148
+225,386
| +10% | +$8.33M | ﹤0.01% | 1884 |
|
2018
Q3 | $81.4M | Buy |
2,167,762
+77,374
| +4% | +$2.91M | ﹤0.01% | 2090 |
|
2018
Q2 | $82.6M | Buy |
2,090,388
+201,780
| +11% | +$7.97M | ﹤0.01% | 2055 |
|
2018
Q1 | $48.7M | Buy |
1,888,608
+734,401
| +64% | +$18.9M | ﹤0.01% | 2275 |
|
2017
Q4 | $31.1M | Buy |
1,154,207
+12,505
| +1% | +$337K | ﹤0.01% | 2524 |
|
2017
Q3 | $42.7M | Buy |
1,141,702
+120,770
| +12% | +$4.51M | ﹤0.01% | 2356 |
|
2017
Q2 | $25.5M | Buy |
+1,020,932
| New | +$25.5M | ﹤0.01% | 2637 |
|